Where I see patients (1)
My work
Cutting-edge breast cancer care
Learn about the latest findings on breast cancer risk, screening and treatment from Dr. Esserman.
Should low-risk tumors still be called cancer?
Dr. Esserman explains how using a different term could reduce unnecessary worry over cancers that are unlikely to be life-threatening.
My reviews
Selected research
-
Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
RE: Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density.
Journal of the National Cancer Institute
-
Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers.
bioRxiv : the preprint server for biology
Clinical trials
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Time to reach a durable COVID-19 level 4 or less or discharge at COVID-level 4 or lower (except for discharge to another hospital), and time to death (mortality). Data will be analyzed for 3 groups: All COVID-19 level 6/7 (those i...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-7070
4.8